The integration of K48-linked di- or tetra-ubiquitin chains onto the side chain of Lys12 of alpha-synuclein significantly inhibits fibril formation and regulates clearance, presenting potential therapeutic strategies for managing PD-related alpha-synuclein toxicity (Kim et al. 2011; Zhang et al. 2019). This evidence concerns the gene SNCA and Parkinson disease.